Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-21
DOI
10.1038/s41598-019-48554-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bacillus coagulans Unique IS2 in Constipation: A Double-Blind, Placebo-Controlled Study
- (2019) Ratna Sudha Madempudi et al. Probiotics and Antimicrobial Proteins
- A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies
- (2018) Bruno K. Rodiño-Janeiro et al. ADVANCES IN THERAPY
- Systematic review: probiotics in the management of lower gastrointestinal symptoms - an updated evidence-based international consensus
- (2018) A. P. S. Hungin et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled study
- (2018) M. Ratna Sudha et al. Beneficial Microbes
- Gut Microbiota-Based Therapies for Irritable Bowel Syndrome
- (2018) Emily K Stern et al. Clinical and Translational Gastroenterology
- Irritable Bowel Syndrome: Patient-Provider Interaction and Patient Education
- (2018) Albena Halpert Journal of Clinical Medicine
- Antiproliferative Effects of Bacillus coagulans Unique IS2 in Colon Cancer Cells
- (2017) Ratna Sudha Madempudi et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Bacillus As Potential Probiotics: Status, Concerns, and Future Perspectives
- (2017) Fouad M. F. Elshaghabee et al. Frontiers in Microbiology
- Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome
- (2017) Brian Lacy et al. Journal of Clinical Medicine
- Validity and reliability of the Bristol Stool Form Scale in healthy adults and patients with diarrhoea-predominant irritable bowel syndrome
- (2016) M. R. Blake et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Global Cytokine Profiles and Association With Clinical Characteristics in Patients With Irritable Bowel Syndrome
- (2016) Sean M P Bennet et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis
- (2016) Yan Zhang et al. BMC GASTROENTEROLOGY
- The Intestinal Microenvironment and Functional Gastrointestinal Disorders
- (2016) Giovanni Barbara et al. GASTROENTEROLOGY
- Systematic review: instruments to assess abdominal pain in irritable bowel syndrome
- (2015) Z. Mujagic et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Evaluation of anti-inflammatory activity of probiotic on carrageenan-induced paw edema in Wistar rats
- (2015) Himanshu K. Solanki et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study
- (2015) Muhammed Majeed et al. Nutrition Journal
- Change of Fecal Flora and Effectiveness of the Short-term VSL#3 Probiotic Treatment in Patients With Functional Constipation
- (2015) Seong-Eun Kim et al. Journal of Neurogastroenterology and Motility
- Irritable bowel syndrome: Pathogenesis, diagnosis, treatment, and evidence-based medicine
- (2014) Lekha Saha WORLD JOURNAL OF GASTROENTEROLOGY
- Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome
- (2013) Yehuda Ringel et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Effect of multispecies probiotics on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial
- (2013) Jun Sik Yoon et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- An evaluation of the FDA Responder Endpoint for IBS-C clinical trials: analysis of data from linaclotide Phase 3 clinical trials
- (2013) J. E. MacDougall et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Irritable Bowel Syndrome: A Review and Update
- (2012) Kaitlin Occhipinti et al. Clinics in Colon and Rectal Surgery
- Clinical Study of Bacillus coagulans Unique IS-2 (ATCC PTA-11748) in the Treatment of Patients with Bacterial Vaginosis
- (2011) M. Ratna Sudha et al. INDIAN JOURNAL OF MICROBIOLOGY
- Decreased Interleukin-10 Secretion by Peripheral Blood Mononuclear Cells in Children With Irritable Bowel Syndrome
- (2011) Man-Chin Hua et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Bacillus spp. of Human Origin: A Potential Siderophoregenic Probiotic Bacteria
- (2010) Jayesh J. Ahire et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- Effects of a propietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome
- (2010) B.J. Dolin METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
- Interleukin-6: a local pain trigger?
- (2010) Camilla I Svensson ARTHRITIS RESEARCH & THERAPY
- Comparative accounts of probiotic characteristics of Bacillus spp. isolated from food wastes
- (2009) Anil K. Patel et al. FOOD RESEARCH INTERNATIONAL
- Original Research:Bacillus coagulansSignificantly Improved Abdominal Pain and Bloating in Patients with IBS
- (2009) Larysa Hun POSTGRADUATE MEDICINE
- Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study
- (2008) E. A. WILLIAMS et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation